AVADEL PHARMACEUTICALS - COM (AVDL)
Historical Holders from Q4 2016 to Q3 2025
-
Type / Class
-
Equity / COM
-
Symbol
-
AVDL on Nasdaq
-
Price per share
-
$15.27
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
737,501
-
Total reported value
-
$11,261,641
-
Share change
-
0
-
Number of holders
-
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025,
AVADEL PHARMACEUTICALS - COM (AVDL) has
3
institutional shareholders
filing 13F forms.
They hold
737,501 shares.
.
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
737,501
|
$11,261,641
|
|
|
$0
|
$15.27
|
3
|
|
2025 Q2
|
737,501
|
$6,526,891
|
|
|
$215,475
|
$8.85
|
3
|
|
2025 Q1
|
737,501
|
$5,774,641
|
+$3,915
|
|
|
$7.83
|
3
|
|
2024 Q4
|
737,001
|
$7,745,886
|
-$4,367,115
|
|
|
$10.51
|
3
|
|
2024 Q3
|
1,070,001
|
$14,032,886
|
-$83,726,145
|
|
|
$13.12
|
5
|
|
2024 Q2
|
7,025,014
|
$98,771,327
|
-$1,024,949,936
|
$0
|
$0
|
$14.06
|
10
|
|
2024 Q1
|
67,722,532
|
$1,143,898,167
|
+$203,068,084
|
$34,279,944
|
$16,825,818
|
$16.89
|
118
|
|
2023 Q4
|
56,101,941
|
$792,157,961
|
+$22,530,113
|
$4,454,860
|
$11,856,564
|
$14.12
|
111
|
|
2023 Q3
|
54,278,206
|
$559,092,743
|
+$10,494,218
|
$3,010,690
|
$7,887,895
|
$10.30
|
97
|
|
2023 Q2
|
51,954,100
|
$856,215,990
|
+$74,681,603
|
$10,166,376
|
$11,691,712
|
$16.48
|
100
|
|
2023 Q1
|
48,372,275
|
$443,043,185
|
+$137,759,207
|
$4,475,576
|
$13,752,824
|
$9.16
|
89
|
|
2022 Q4
|
33,455,552
|
$239,492,674
|
+$16,050,496
|
$8,356,116
|
$10,367,328
|
$7.16
|
83
|
|
2022 Q3
|
31,382,476
|
$157,240,505
|
-$10,626,389
|
$6,324,000
|
$3,960,000
|
$5.01
|
73
|
|
2022 Q2
|
33,736,494
|
$82,314,348
|
-$28,513,599
|
$2,235,000
|
$2,576,000
|
$2.44
|
76
|
|
2022 Q1
|
35,805,994
|
$244,546,225
|
-$688,773
|
$2,334,000
|
$4,920,000
|
$6.83
|
78
|
|
2021 Q4
|
34,932,136
|
$282,263,295
|
+$4,296,837
|
$3,562,552
|
$5,900,000
|
$8.08
|
80
|
|
2021 Q3
|
32,066,701
|
$314,225,653
|
-$2,362,887
|
$1,584,800
|
$14,101,680
|
$9.80
|
81
|
|
2021 Q2
|
32,560,006
|
$219,142,519
|
-$1,408,221
|
$1,585,730
|
$2,988,033
|
$6.73
|
78
|
|
2021 Q1
|
32,624,275
|
$294,399,454
|
+$1,571,028
|
$2,641,000
|
$2,583,000
|
$9.04
|
77
|
|
2020 Q4
|
32,022,142
|
$213,943,727
|
+$3,675,725
|
$1,058,000
|
$846,000
|
$6.68
|
79
|
|
2020 Q3
|
31,489,522
|
$158,737,955
|
-$40,676,485
|
$812,000
|
$1,032,000
|
$5.04
|
77
|
|
2020 Q2
|
36,267,175
|
$293,031,072
|
+$73,438,051
|
$2,990,000
|
$3,192,000
|
$8.08
|
73
|
|
2020 Q1
|
26,858,841
|
$211,297,159
|
+$55,745,053
|
$2,816,000
|
$21,718,000
|
$7.94
|
55
|
|
2019 Q4
|
18,381,676
|
$138,778,000
|
+$3,405,718
|
$1,376,000
|
$1,476,000
|
$7.55
|
42
|
|
2019 Q3
|
19,369,854
|
$80,579,000
|
+$264,036
|
$239,000
|
$308,000
|
$4.16
|
40
|
|
2019 Q2
|
19,348,881
|
$55,916,464
|
-$532,703
|
$92,000
|
|
$2.89
|
41
|
|
2019 Q1
|
19,605,364
|
$28,234,677
|
-$885,274
|
$0
|
|
$1.44
|
39
|
|
2018 Q4
|
19,797,043
|
$51,037,773
|
-$3,326,792
|
$54,000
|
$0
|
$2.58
|
49
|
|
2018 Q3
|
20,161,887
|
$88,500,210
|
-$2,841,826
|
$270,000
|
$160,000
|
$4.39
|
63
|
|
2018 Q2
|
20,601,522
|
$126,287,755
|
-$36,188,917
|
$553,000
|
$364,000
|
$6.13
|
67
|
|
2018 Q1
|
25,894,045
|
$188,761,103
|
-$4,895,064
|
$831,000
|
$597,000
|
$7.29
|
72
|
|
2017 Q4
|
26,385,773
|
$216,351,759
|
-$17,017,220
|
$388,000
|
|
$8.20
|
76
|
|
2017 Q3
|
27,182,084
|
$284,631,551
|
-$5,504,957
|
$279,000
|
|
$10.50
|
79
|
|
2017 Q2
|
27,736,858
|
$305,936,220
|
+$24,728,608
|
|
$0
|
$11.03
|
76
|
|
2017 Q1
|
27,900,060
|
$270,237,807
|
+$228,176,242
|
|
$131,000
|
$9.68
|
70
|
|
2016 Q4
|
4,300,449
|
$44,678,000
|
+$44,678,000
|
|
|
$10.39
|
6
|